A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Clinical trial NCT07465653 · RECRUITING
Trial details
- NCT number
- NCT07465653
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-18
- Primary completion
- 2026-09-24
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.